Hematology Joint Venture Clause Samples

Hematology Joint Venture. IRIS, BM and CIL agree that the parties to the Securities Purchase Agreement fulfilled their respective obligations under Section 5 thereof (Joint Venture to Develop Hematology Workstation) regarding the negotiation of a potential joint venture to develop, manufacture and market a hematology workstation. The option for further cooperation expired without being exercised, and the parties shall have no further obligations under Section 5 of the Securities Purchase Agreement.